#Canada #Toronto #Precision Medicine #Oncology Trials #Xtalks

Tackling Operational Gaps in Oncology Clinical Trials

In the rapidly evolving field of oncology, clinical trials have become increasingly challenging due to precision medicine introducing complex protocols, restrictive eligibility criteria, and a fragmented patient population. This upcoming free webinar hosted by Xtalks aims to address these operational gaps that hinder the efficiency of oncology clinical trials and explore strategies for overcoming them.

Understanding the Operational Barriers

The difficulties arise from several angles:
1. From the Oncologist's Viewpoint:
As treatments become more personalized, oncologists face narrowing molecular subtype requirements and updated tissue acquisition protocols, complicating patient eligibility. This shift can create challenges in identifying suitable candidates for trials.

2. From the Site's Perspective:
Limited infrastructures for screening, inconsistent genomic testing, and disjointed referral pathways create unpredictability in recruitment, causing further delays in trial initiation.

3. From the Sponsor and CRO Standpoint:
The current disconnected data systems, bottlenecks in screening processes, and high screen failure rates can result in trial delays, posing additional strains on timelines and operational efficiency.

By garnering insights from industry experts during the webinar, attendees will unpack these challenges from all relevant perspectives including that of physicians, clinical sites, sponsors, and contractual research organizations (CROs).

Key Topics of Discussion

In this session, the speakers, which include experienced professionals from the oncology sector, will discuss:

• - The impact of biomarker-driven eligibility on patient recruitment
• - Common operational challenges and how they impede screening and enrollment
• - Strategies for improving connectivity in data systems to support operational workflows in trials
• - Practical methodologies for enhancing site readiness and patient identification

A coordinated approach is vital to streamline processes and mitigate delays stemming from operational bottlenecks, ultimately enabling quicker and more reliable progress in oncology studies.

Register Now

Join us for this critical webinar scheduled for May 26, 2026, at 11 AM EDT. Listen and engage with:

• - Dannelle Palmer, MBA, Chief of Staff at Humaneva
• - Scott Schliebner, COO of P1 Pratia Oncology
• - Dr. Julio A. Peguero, President of P1 Pratia Oncology
• - Dr. Brandon Fletcher, Medical Affairs at Kapadi
• - Melanie Marshall, Associate Director of Data Quality Management at Kapadi

Don’t miss out on this opportunity to learn from leading experts in the field about streamlining oncology clinical trials through improved operational design.

For registration information, visit the Xtalks website.

About Xtalks

Xtalks is a renowned platform dedicated to advancing the life science community, providing reliable insights and facilitating discussions that drive the industry forward. Through webinars, articles, and expert-led discussions, Xtalks supports professionals in staying informed and connected in a rapidly changing landscape. To learn more about Xtalks and find upcoming events, visit www.xtalks.com.

Join us and be part of the conversation to help refine oncology clinical trials for the future of patient care.